|
|
||||||||
a UCLA Molecular Biology Institute, Los Angeles, California, USA;
b Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, Los Angeles, California, USA;
c Department of Biological Chemistry, UCLA School of Medicine; Los Angeles, California, USA
Key Words. Notch1 • Notch2 • Jagged1 • Delta1 • Hematopoiesis • Fetal
Judith C. Gasson, Ph.D., Jonsson Comprehensive Cancer Center, 8-684 Factor, UCLA, Box 9517821, Los Angeles, California 90095-1781, USA. Telephone: 310-825-5268; Fax: 310-206-5553; e-mail: jgasson{at}mednet.ucla.edu
Members of the Notch family of transmembrane receptors are found on primitive hematopoietic precursors, and Notch ligand expression has been demonstrated on the surface of stromal cells, suggesting a role for Notch signaling in mammalian blood cell development. The current report examines the expression of Notch receptors and their ligands in murine hematopoietic tissues to determine: A) which blood cell lineages in the adult are influenced by Notch activity, and B) whether fetal hematopoiesis in the embryo involves the Notch pathway. In the adult mouse, a combination of flow cytometry, immunohistochemistry and Northern analysis was used to examine Notch receptor or ligand expression in bone marrow and spleen. In the embryo, Northern analysis and in situ hybridization were used to characterize Notch receptor and ligand expression in fetal liver on embryonic day 12 (E12) through E17, an active period encompassing both erythropoiesis and granulopoeisis. Flow cytometry demonstrated the presence of Notch1 and Notch2 receptors on bone marrow-derived myeloid cells but not on erythroid cells positive for the marker, Ter-119. In situ hybridization of E12 through E17 fetal liver demonstrated widespread expression of Jagged1 and Delta1 in a pattern similar to but less abundant than that of the erythropoietin receptor. Taken together with earlier functional results, the current expression data suggest a role for Notch activity in establishing definitive hematopoiesis in fetal liver, as well as a selective use of Notch signaling in adult erythropoiesis and granulopoiesis. Notch receptors in the adult are most likely utilized by early erythroid precursors and intermediate-stage granulocytes, but not by terminally differentiating cells of either subset.
This article has been cited by other articles:
![]() |
M. Gabbianelli, O. Morsilli, A. Massa, L. Pasquini, P. Cianciulli, U. Testa, and C. Peschle Effective erythropoiesis and HbF reactivation induced by kit ligand in -thalassemia Blood, January 1, 2008; 111(1): 421 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ganapati, H. T. Tan, M. Lynch, M. Dolezal, S. de Vos, and J. C. Gasson Modeling Notch Signaling in Normal and Neoplastic Hematopoiesis: Global Gene Expression Profiling in Response to Activated Notch Expression Stem Cells, August 1, 2007; 25(8): 1872 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. de Pooter, T. M. Schmitt, J. L. de la Pompa, Y. Fujiwara, S. H. Orkin, and J. C. Zuniga-Pflucker Notch Signaling Requires GATA-2 to Inhibit Myelopoiesis from Embryonic Stem Cells and Primary Hemopoietic Progenitors J. Immunol., May 1, 2006; 176(9): 5267 - 5275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. La Motte-Mohs, E. Herer, and J. C. Zuniga-Pflucker Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro Blood, February 15, 2005; 105(4): 1431 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Hadland, S. S. Huppert, J. Kanungo, Y. Xue, R. Jiang, T. Gridley, R. A. Conlon, A. M. Cheng, R. Kopan, and G. D. Longmore A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development Blood, November 15, 2004; 104(10): 3097 - 3105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Milchanowski, A. L. Henkenius, M. Narayanan, V. Hartenstein, and U. Banerjee Identification and Characterization of Genes Involved in Embryonic Crystal Cell Formation During Drosophila Hematopoiesis Genetics, September 1, 2004; 168(1): 325 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nefedova, P. Cheng, M. Alsina, W. S. Dalton, and D. I. Gabrilovich Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines Blood, May 1, 2004; 103(9): 3503 - 3510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Witt, V. Hurez, C. S. Swindle, Y. Hamada, and C. A. Klug Activated Notch2 Potentiates CD8 Lineage Maturation and Promotes the Selective Development of B1 B Cells Mol. Cell. Biol., December 1, 2003; 23(23): 8637 - 8650. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Yun and M. J. Bevan Notch-Regulated Ankyrin-Repeat Protein Inhibits Notch1 Signaling: Multiple Notch1 Signaling Pathways Involved In T Cell Development J. Immunol., June 15, 2003; 170(12): 5834 - 5841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
